Even as the weather is getting colder in most countries, the COVID-19 pandemic continues spreading even as there have been some improvements in certain places. Researchers have now revealed that the virus can still spread regardless of the weather.
Millions of people all over the world are still suffering from COVID-19, with hundreds of thousands dying from the disease. There has yet to be a cure for the disease and there has been some speculation on whether COVID-19 is a seasonal disease. Unfortunately, according to researchers from the University of Texas, temperature and humidity have no impact whatsoever on COVID-19. Their findings are in line with the research done by the World Health Organization.
“The effect of weather is low and other features such as mobility have more impact than weather,” said Professor Dev Niyogi, who is also the lead author of the study. “In terms of relative importance, weather is one of the last parameters.”
In the study, the researchers combined temperature and humidity as one value in determining their findings. They analyzed how the values correlated with the spread of COVID-19 to different areas between March and July 2020. The study spanned from US states to other countries and the rest of the world. They also analyzed the relationship between COVID-19 transmission and human behavior using smartphone data to study movement habits.
They came to the conclusion that the weather had no influence over coronavirus transmission. The effect of the weather was only at three percent, without any indication of the kind of weather that could have more impact on the spread.
Meanwhile, a group of scientists from the University of Washington was able to develop a potential COVID-19 cure. The group has claimed that the vaccine could trigger a very strong response in the body’s immune system. They published their findings in the science magazine Cell, revealing that initial trials were done on mice. The group also touted that the vaccine would not need freezer storage which would make it easier to ship and distribute worldwide.
The group has yet to confirm the potency of their vaccine through human trials.


Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Tabletop particle accelerator could transform medicine and materials science
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 



